Skip to content

PO²

Active Private limited companyfounded 2015active for 11 yearsRue Paul-Verlaine 1, 6850 PaliseulKBO/BCE: BE 0598.929.369 #4 company by total assets in Paliseul, Wholesale and retail trade sector

Lifetime

11 annual accounts with figures on one time axis
peak of €145,446 in 2017
€96,054▼ 28.2%
lowest -€48,617 in 2025
-€48,617▼ €146,165
peak of €1.1m in 2024
€1.1m▼ 4.4%
€1.2m▲ 3.9%
Board4 names since 2015
2 directors and 1 other
Documentsfilings and deeds
15-06-202646 days before the deadline
2025abbreviated format
Gross margin from €133,799 to €96,054Loss of €48,617Merger: PO² takes over PHARMA BIOMED 02-05Cash from €73,481 to €359,699

Key points

from the 2025 annual accounts

Result

-€48,617 -€48,617
€97,5002024-€48,6002025

From profit to loss in 2025, after a profit of €97,548 in 2024.

Investments

€1.3m 11.7 times depreciation
20232025

Green is investment, beige is depreciation.

Liquidity

1.14 was 0.21 in 2024

Short-term debts fell from €562,377 to €354,476.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

The last five annual accounts were filed 5 to 46 days before the end of the period.

Position in the sector

-€48,617

Lower net result than 89% of companies in retail trade. Sector median €37,991 · 13,252 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,689 companies had the same profile as PO² has now. Each dot stands for 7 companies, two years later.

93.6%
were still trading
5.5%
stopped another way
0.6%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,689 companies, not a prediction for PO². The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 112 sharesdeed of 16-10-2026
  • 74 sharesdeed of 16-10-2026

Shares in 1 company,

Board & ownership

Recent changes

Registered office moved within Paliseul The registered office moved from Grand-Place, 16 6850 Paliseul to rue Paul Verlaine, 1 6850 Paliseul · holds 112 shares · holds 74 shares · General meeting of 03-08-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0598929369
Merger: PO² takes over PHARMA BIOMED Appointments: (director) and (director) · “L'achat, la location et la gestion d'officines pharmaceutiques; A la vente de gros et en détail et à la…” (deed in French) · General meeting of 02-04-2025 · Gazette deed
Merger proposal: PO² takes over PHARMA BIOMED Permanent representative: · The company holds all the shares of PHARMA BIOMED · Gazette deed
All 28 events

Comparable companies

same main activity, similar in size and age
Company
PO² Paliseul €2.3m €96,054 45.3% -
ASAPHARM Gembloux €1.9m €97,106 8.6% 0
DSTM HOLDING Léglise €2.1m €62,179 14.3% -
Nicolas PUTOIS Chaudfontaine €2.1m €75,817 15.2% -
PHARMACIE MERCADIER Waterloo €1.7m €109,409 36.7% -
CHRISTELLE DEROUX Braine-l'Alleud €2.9m €124,047 48.0% -
SikaCare Hasselt €1.8m €125,616 34.2% 0

These companies have the same main activity as PO²: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.7m and €2.9m, founded between 2011 and 2017.

Official details

Source: KBO
Status
Active since 24-02-2015Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.240.292.7966850 Paliseul, since 24-02-2015
Financial year end
31 December
Peppol
Reachable since 24-11-2025
Company details

Annual accounts 2025

≈ €460,000estimated
€2.3m▲ 3.9%
Filing
Filed on 15-06-2026, 46 days before the end of the filing period
Financials

Insights on PO²

PO² files the abbreviated format. That format states no turnover. The gross margin rose from €43,574 in 2015 to €96,054 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PO²

What is the company number of PO²?
The company number of PO² is 0598.929.369. The VAT number is the same number with BE in front: BE 0598.929.369.
Where is PO² based?
The registered office is at Rue Paul-Verlaine 1, 6850 Paliseul.Company details
What does PO² do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PO²?
PO² is a private limited company (BV).
When was PO² founded?
PO² was founded on 24-02-2015.
Is PO² still active?
Yes, PO² is an active enterprise in the KBO register.
What is the turnover of PO²?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €96,054 and 76 comparable companies (NACE 477). It probably lies between €230,000 and €670,000.Financials
Is PO² profitable?
In financial year 2025, PO² made a loss of €48,617.
Where can I find the annual accounts of PO²?
PO² filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PO² due?
PO² must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.